Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2024 Feb 16;26(5):983. doi: 10.1093/neuonc/noae024

Corrigendum to: Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group

PMCID: PMC11066902  PMID: 38366877

This is a corrigendum to: Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Peter de Blank, Roger J Packer, Maryam Fouladi, Antoinette Schouten van Meeteren, David Jones, Arie Perry, Yoshiko Nakano, Darren Hargrave, David Riedl, Nathan J Robison, Marita Partanen, Michael J Fisher, Olaf Witt, Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group, Neuro-Oncology, 2023;, noad227, https://doi.org/10.1093/neuonc/noad227.

In the originally published version of this manuscript, there was an error in the spelling of author Nathan J Robison’s name. This has been corrected.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES